We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Cellectricon Partners with The Automation Partnership

Read time: Less than a minute

Cellectricon has announced the signing of a collaborative agreement with The Automation Partnership (TAP) in the UK, manufacturers of advanced automated systems for cell culture, sample management and high throughput screening applications.

Under the agreement TAP will co-develop and manufacture the Dynaflow®HT System, Cellectricon’s next generation high throughput ion channel screening platform. Dynaflow®HT will be launched and commercially available in 2009.

Addressing the limitations of current ion channel screening technologies, the Dynaflow®HT yields a level of automated throughput while still delivering measurement data quality. The concept and technology has been developed and validated over the last three years by Cellectricon in partnership with AstraZeneca.

“We are excited to partner with TAP who are world-renowned for manufacturing industrial quality automation”, says Jonas Ohlsson, CEO at Cellectricon. “To bring this fully automated state-of-the-art high throughput electrophysiology system to the market is a milestone for ion channel screening. The system offers unmatched throughput, cost per data point and reliability/predictability”.